Amano Enzyme USA breaks ground on facility expansion
The construction on Amano Enzyme's Elgin, IL facility began on May 28, 2024, and is expected to be complete by April 2025. The expansion is expected to add 29,827 square feet to its warehouse, production, and office areas.
image courtesy of Amano Enzyme USA Co. Ltd. From left to right: Garth Wade, Logistics Manager, Yoshiki Sato, Quality Control Manager, Sam Lazar, Operations Manager, Kenichi Nishimatsu, President, Viet Ha, Technical Sales Manager, Liangji Xu, Technical Services Manager, Andrew Piorkowski, Quality Assurance Manager.
Amano Enzyme USA Co. Ltd. (Elgin, IL), has announced that is has broken ground on a facility expansion of its Elgin, IL manufacturing site. The construction began on May 28, 2024, and is expected to be complete by April 2025. The expansion is expected to add 29,827 square feet to its warehouse, production, and office areas. The company says that once construction is completed, the expansion will continue into the technical services area of the manufacturing site.
“Elgin is a key manufacturing facility in the USA, and we are thrilled to commemorate this moment of growth for our team, our products that are being marketed in North, Central and South America, along with all of our customer partners in these regions,” said Ken Nishimatsu, president of Amano Enzyme USA, in a press release. “We’re confident that by investing in our facilities such as the Elgin site, Amano Enzyme will continue to uphold our commitment to the highest standards of quality, manufacturing operations and technical knowledge.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
